Oxford to lead trial of experimental drug in Ebola patients

Ebola virus. Credit: Festa/Shutterstock
A clinical trial is to be carried out in West Africa to see whether a novel antiviral drug called brincidofovir is effective against Ebola, subject to regulatory approval.
The trial, involving an international team led by Oxford University scientists, will take place in an Ebola treatment centre run by Médecins Sans Frontières (MSF).